On this page
CHRNG
cholinergic receptor nicotinic gamma subunit
The CHRNG gene provides instructions for a subunit of the acetylcholine receptor, a critical protein for nerve-muscle signalling during foetal development. The CHRNG gene encodes the gamma subunit of the foetal acetylcholine receptor (AChR), which is vital for communication between nerve and muscle cells.
CHRNG is located on the long (q) arm of chromosome 2, at band 2q37.1. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 2 in the library →Available at Jeen Health
Clinical tests that include this
Overview
The CHRNG gene, or cholinergic receptor nicotinic gamma subunit, plays a crucial role in the development of the neuromuscular system. It is responsible for producing a specific component of the acetylcholine receptor (AChR), a protein found in skeletal muscle cell membranes. This receptor is fundamental for transmitting signals from nerves to muscles, enabling movement and muscle contraction. The protein encoded by CHRNG is specifically found in the foetal form of the AChR, highlighting its importance during early development.
What the gene does
The CHRNG gene provides the genetic blueprint for the gamma (γ) subunit, a key component of the acetylcholine receptor (AChR) protein. This receptor, located in the membrane of skeletal muscle cells, facilitates essential signalling between nerve cells and muscle cells, which is necessary for muscle contraction and movement. The AChR protein is typically composed of five subunits, each derived from a different gene, which assemble to form the functional receptor. While the γ subunit is exclusively part of the foetal AChR, it is later replaced by the epsilon (ε) subunit (encoded by the CHRNE gene) around the 33rd week of pregnancy to form the adult version of the receptor. This transition underscores the specific developmental role of the CHRNG-encoded protein in early muscle function.
Video: Genetics 101
Chromosome location
The CHRNG gene is situated on chromosome 2, specifically at position 2q37.1. This precise genomic location indicates where the gene resides within the human genome. The gene spans a region that contributes to its overall structure and function in encoding the gamma subunit of the acetylcholine receptor.
Protein structure
Domain architecture has not been experimentally characterised in detail for this protein.
Key variants
Variants within the CHRNG gene can alter the structure or function of the gamma subunit of the acetylcholine receptor. These genetic changes can range from single DNA base substitutions to larger deletions or insertions of genetic material. Such variants may lead to an impaired or entirely absent gamma subunit, affecting the overall function of the foetal acetylcholine receptor and potentially disrupting nerve-muscle communication.
Sample of pathogenic variants
10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.1021C>T | p.Arg341Ter | Pathogenic/Likely pathogenic | ★★☆☆ | CHRNG-related disorder |
c.137_141del | p.Arg46fs | Pathogenic/Likely pathogenic | ★★☆☆ | Lethal multiple pterygium syndrome |
c.202C>T | p.Arg68Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Lethal multiple pterygium syndrome |
c.240+1del | - | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal recessive multiple pterygium syndrome |
c.274C>T | p.Arg92Ter | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal recessive multiple pterygium syndrome |
c.350+2T>C | - | Pathogenic/Likely pathogenic | ★★☆☆ | Autosomal recessive multiple pterygium syndrome |
c.402del | p.Asp135fs | Pathogenic/Likely pathogenic | ★★☆☆ | Lethal multiple pterygium syndrome |
c.420G>A | p.Trp140Ter | Pathogenic | ★★☆☆ | Autosomal recessive multiple pterygium syndrome |
c.532_533del | p.Glu177_Ile178insTer | Pathogenic/Likely pathogenic | ★★☆☆ | Lethal multiple pterygium syndrome |
c.56-1G>A | - | Pathogenic | ★★☆☆ | Autosomal recessive multiple pterygium syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Variants in the CHRNG gene are associated with conditions that affect muscle development and movement, particularly during foetal life. One such condition is multiple pterygium syndrome, characterised by features such as webbing of the skin (pterygia) and reduced muscle movement (akinesia) before birth. These conditions often arise from the impaired or absent function of the gamma subunit due to CHRNG gene variants.
No disease links recorded for this gene in our reference set.
UK clinical status
The CHRNG gene is recognised within the UK's NHS Genomic Medicine Service, featuring on several NHS England's National Genomic Test Directory panels. It is listed on the Arthrogryposis (R83), Congenital myasthenic syndrome (R80), Foetal anomalies (R21), Clefting, and Foetal hydrops panels. This inclusion indicates its clinical relevance for genetic testing and diagnosis within these areas.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does the CHRNG gene do?
The CHRNG gene provides instructions for making the gamma subunit of the foetal acetylcholine receptor. This receptor is critical for communication between nerve cells and muscle cells, which is essential for muscle movement during early development.
What conditions are associated with CHRNG gene variants?
Variants in the CHRNG gene are primarily associated with multiple pterygium syndrome. This condition is characterised by features such as skin webbing and reduced muscle movement that develop before birth, due to impaired receptor function.
Is the CHRNG gene involved in adult muscle function?
The CHRNG gene specifically contributes to the foetal form of the acetylcholine receptor. Around the 33rd week of pregnancy, the gamma subunit is replaced by the epsilon subunit to form the adult acetylcholine receptor, meaning CHRNG has a more pronounced role in foetal development.
References
- Michalk A, Stricker S, Becker J. Acetylcholine receptor pathway mutations explain various fetal akinesia deformation sequence disorders. American journal of human genetics. 2008. PMID: 18252226
- Hoffmann K, Muller JS, Stricker S. Escobar syndrome is a prenatal myasthenia caused by disruption of the acetylcholine receptor fetal gamma subunit. American journal of human genetics. 2006. PMID: 16826520
- Morgan NV, Brueton LA, Cox P. Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome. American journal of human genetics. 2006. PMID: 16826531